Yury Fedotov, UNODC. My special thanks to Member States, civil society and UN partners in organizing this important event. I also welcome the many distinguished speakers who are with us today. In the discussions leading to next month’s General Assembly special session on the world drug problem, we have seen a growing emphasis on the …
International Drug Policy Consortium (IDPC)
Side Event: Harm reduction and the UNGASS: Feedback from the Expert Group Meeting in Berlin
Side event organised by Germany, GIZ and the International Drug Policy Consortium The Conference Room paper is available here. Marlene Mortler MP, Drug Commissioner of the Federal Government of Germany. On behalf of the German delegation at CND, I am delighted to welcome all of you to this important event, and I would like to thank …
Side event: Towards the abolition of the death penalty for drug offences
Side event organised by Harm Reduction International, Reprieve, Amnesty International, Penal Reform International and the International Drug Policy Consortium. Maria Phelan, Harm Reduction International. The death penalty continues to be a very prominent issue in the debate today. Luiz Guilherme Mendes de Paiva, Brazil. Last year we had some interesting conversations around the death penalty. We were in …
Side Event: Improving system-wide coherence by reprioritising metrics to evaluate illicit drug policy
Side event organised by ICSDP, GDPO, Transform, IDPC, Switzerland, Mexico and Brazil. Dave Bewley-Taylor, University of Swansea Global Drug Policy Observatory. The Sustainable Development Goals that have been agreed by the United Nations further amplify the need for better drug policy metrics. Drugs can be seen as influential across all the Sustainable Development Goals – …
Side event – Decriminalising drug use: Concept and practice
Side event organised by the International Drug Policy Consortium (IDPC), the Czech Republic, and Release. Marie Nougier, Senior Research and Communications Officer, International Drug Policy Consortium – Decriminalisation is essential for a health-based approach to drugs. It has broad support from, among others, WHO, OHCHR and UNAIDS. But there are a lot of differences in how …
Informal Interactive Stakeholder Consultation
OPENING SEGMENT H.E. Mr. Mogens Lykketoft, President of the UN General Assembly Welcome to the IISC in support of the UNGASS meeting. UNGASS is a major event in the 2016 GA calendar. What we are facing in these discussions is a transnational threat represented by the world drug problem and representing the common challenge and …